PROTECTOR / FIRE‑10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to

Robert Siegel1, Luca Dittrich1, Julius Plewe1

  • 1Department of Surgery, Campus Charité Mitte | Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

BMC Cancer
|March 20, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos